Exposure to exogenous gangliosides and Guillain-Barré syndrome.
Beghi
E
E
D005732:Gangliosides / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011129:Polyradiculoneuropathy / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D016896:Treatment Outcome
D005732:Gangliosides